Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5201396
Max Phase: Preclinical
Molecular Formula: C16H16N6OS
Molecular Weight: 340.41
Associated Items:
ID: ALA5201396
Max Phase: Preclinical
Molecular Formula: C16H16N6OS
Molecular Weight: 340.41
Associated Items:
Canonical SMILES: Cc1cccnc1Nc1nc(-c2cc(C(=O)N(C)C)ccn2)ns1
Standard InChI: InChI=1S/C16H16N6OS/c1-10-5-4-7-18-13(10)19-16-20-14(21-24-16)12-9-11(6-8-17-12)15(23)22(2)3/h4-9H,1-3H3,(H,18,19,20,21)
Standard InChI Key: IOUILBBYZQRVKV-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 340.41 | Molecular Weight (Monoisotopic): 340.1106 | AlogP: 2.75 | #Rotatable Bonds: 4 |
Polar Surface Area: 83.90 | Molecular Species: ACID | HBA: 7 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 6.49 | CX Basic pKa: 3.17 | CX LogP: 2.82 | CX LogD: 1.95 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.79 | Np Likeness Score: -2.05 |
1. Hawryluk N, Robinson D, Shen Y, Kyne G, Bedore M, Menon S, Canan S, von Geldern T, Townson S, Gokool S, Ehrens A, Koschel M, Lhermitte-Vallarino N, Martin C, Hoerauf A, Hernandez G, Dalvie D, Specht S, Hübner MP, Scandale I.. (2022) Discovery of Substituted Di(pyridin-2-yl)-1,2,4-thiadiazol-5-amines as Novel Macrofilaricidal Compounds for the Treatment of Human Filarial Infections., 65 (16.0): [PMID:35972896] [10.1021/acs.jmedchem.2c00960] |
Source(1):